- Record: found
- Abstract: found
- Article: not found
Phase II trial of weekly paclitaxel for unresectable angiosarcoma: the ANGIOTAX Study.
Nicolas Penel
1 ,
Binh Nguyen Bui ,
Jacques-Olivier Bay ,
Didier Cupissol ,
Isabelle Ray-Coquard ,
Sophie Piperno-Neumann ,
Pierre Kerbrat ,
Charles Fournier ,
Sophie Taieb ,
Marta Jimenez ,
Nicolas Isambert ,
Frédéric Peyrade ,
Christine Chevreau ,
Emmanuelle Bompas ,
Etienne G C Brain ,
Jean-Yves Blay
Nov 10 2008
Read this article at
There is no author summary for this article yet. Authors can add summaries to their articles on ScienceOpen to make them more accessible to a non-specialist audience.
Abstract
The objective of this phase II trial was to assess the efficacy and toxicity of weekly paclitaxel for patients with metastatic or unresectable angiosarcoma.